Priority review granted for first‑in‑class Tourette therapy

First guidance for a licensed hyperhidrosis treatment

Company receives USD 10 million upfront

Partnership expands access to men’s health treatment

Saffron trial delivers positive results

Phase 3 study shows strong efficacy

Rigel makes Veppanu available across US

Study begins testing KJ‑103 in TROP2‑positive cancers

New alliance aims to accelerate development of future medicines

KUP101 enters clinic for advanced solid tumours